Polyethylenimine-DNA Nanoparticles Under Endosomal Acidification and Implication to Gene Delivery
Overview
Authors
Affiliations
Non-viral gene delivery using polyethylenimine (PEI) has shown tremendous promise as a therapeutic technique. Through the formation of nanoparticles (NPs), PEIs protect genetic material such as DNA from degradation. Escape of the NPs from endosomes and lysosomes is facilitated by PEI's buffering capacity over a wide range of pH. However, little is known about the effects of endosomal acidification on the morphology of the NPs. In this work, large-scale coarse-grained simulations performed to mimic endosomal acidification reveal that NPs undergo a resizing process that is highly dependent on the N/P ratio (ratio of PEI nitrogen to DNA phosphate) at which they are prepared. With a low N/P ratio, NPs further aggregate after endosomal acidification, whereas with a high N/P ratio they dissociate. The mechanisms behind such NP resizing and its consequences on endosomal escape and nuclear trafficking are discussed. Based on the findings, suggestions are made on the PEI architecture that may enhance NP dissociation driven by endosomal acidification.
Martini compatible coarse-grained model of polyethylenimine for pulmonary gene delivery.
Lunt G, Hashemi N, Mahajan S, Tang T Sci Rep. 2025; 15(1):4377.
PMID: 39910324 PMC: 11799348. DOI: 10.1038/s41598-025-88848-x.
LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy.
Yan Y, Duan T, Xue X, Yang X, Liu M, Ma B Int J Nanomedicine. 2025; 20:1047-1063.
PMID: 39877587 PMC: 11773180. DOI: 10.2147/IJN.S492734.
Cell membrane-coated mRNA nanoparticles for enhanced delivery to dendritic cells and immunotherapy.
Li Q, Byun J, Kim D, Wu Y, Lee J, Oh Y Asian J Pharm Sci. 2024; 19(6):100968.
PMID: 39640052 PMC: 11617980. DOI: 10.1016/j.ajps.2024.100968.
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery.
Qiu C, Xia F, Zhang J, Shi Q, Meng Y, Wang C Research (Wash D C). 2023; 6:0148.
PMID: 37250954 PMC: 10208951. DOI: 10.34133/research.0148.
Soto A, Nieto-Diaz M, Martinez-Campos E, Noalles-Dols A, Barreda-Manso M, Reviriego F Pharmaceutics. 2023; 15(5).
PMID: 37242702 PMC: 10223979. DOI: 10.3390/pharmaceutics15051451.